Angiotensin-(1–7): an update
Tóm tắt
Từ khóa
Tài liệu tham khảo
Brunner, 1972, Essential hypertension: renin and aldosterone, heart attack and stroke, N Engl J Med, 286, 441, 10.1056/NEJM197203022860901
Page, 1974
Peach, 1977, Renin–angiotensin system: biochemistry and mechanism of action, Physiol Rev, 57, 313, 10.1152/physrev.1977.57.2.313
Haber, 1983, The biochemistry of the renin–angiotensin system, 171
Phillips, 1979, Evidence for an endogenous brain renin–angiotensin system, Fed Proc, 38, 2260
Dzau, 1988, Molecular and physiological aspects of tissue renin–angiotensin system: emphasis on cardiovascular control, J Hypertens, 6, S7
Phillips, 1992, Levels of angiotensin and molecular biology of the tissue renin–angiotensin systems, Regul Pept, 43, 1, 10.1016/0167-0115(93)90403-U
Wollert, 1999, The renin–angiotensin system and experimental heart failure, Cardiovasc Res, 43, 838, 10.1016/S0008-6363(99)00145-5
Murphy, 1991, Isolation of a c-DNA encoding the vascular type-1 angiotensin II receptor, Nature, 351, 233, 10.1038/351233a0
Furuta, 1992, Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor, Biochem Biophys Res Commun, 183, 8, 10.1016/0006-291X(92)91600-U
Mukoyama, 1993, Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors, J Biol Chem, 268, 24539, 10.1016/S0021-9258(19)74498-6
Kambaiashi, 1993, Molecular cloning of a novel angiotensin II isoform involved in phosphotyrosine phosphatase inhibition, J Biol Chem, 268, 24543, 10.1016/S0021-9258(19)74499-8
Inagami, 1999, Molecular biology and signaling of angiotensin receptors: an overview, J Am Soc Nephrol, 10, S2
Ardaillou, 1999, Angiotensin II receptors, J Am Soc Nephrol, 10, S30
Wright, 1992, Regulatory role of brain angiotensins in the control of physiological and behavioral responses, Brain Res Rev, 17, 227, 10.1016/0165-0173(92)90018-H
Griendling, 1996, Angiotensin receptors and their therapeutic implications, Annu Rev Pharmacol Toxicol, 36, 281, 10.1146/annurev.pharmtox.36.1.281
Baltatu, 1998, Functional testing of components of the brain renin–angiotensin system in transgenic animals, 105
Phillips, 1998, Angiotensin II in central nervous system physiology, Regul Pept, 78, 1, 10.1016/S0167-0115(98)00122-0
Ferrario, 1998, Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis, J Am Soc Nephrol, 9, 1716, 10.1681/ASN.V991716
Kim, 2000, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases, Pharmacol Rev, 52, 11
Santos, 1994, Central and peripheral actions of angiotensin-(1–7), Braz J Med Biol Res, 27, 1033
Lynch, 1986, Neuropeptides: multiple molecular forms, metabolic pathways, and receptors, Annu Rev Biochem, 55, 773, 10.1146/annurev.bi.55.070186.004013
Margolius, 1995, Kallikreins and kinins — some unanswered questions about system characteristics and roles in human disease, Hypertension, 26, 221, 10.1161/01.HYP.26.2.221
Bhoola, 1992, Bioregulation of kinins: kallikreins, kininogens, and kininases, Pharmacol Rev, 44, 1
Reijmers, 1998, Vasopressin metabolites: a link between vasopressin and memory?, Prog Brain Res, 119, 523, 10.1016/S0079-6123(08)61591-5
Gutkowska, 1997, Atrial natriuretic peptide in brain and pituitary gland, Physiol Rev, 77, 465, 10.1152/physrev.1997.77.2.465
Maack, 1996, Role of atrial natriuretic factor in volume control, Kidney Int, 49, 1732, 10.1038/ki.1996.257
Stjernquist, 1998, Endothelins — vasoactive peptides and growth factors, Cell Tissue Res, 292, 1, 10.1007/s004410051028
Ferrario, 1997, Counterregulatory actions of angiotensin-(1–7), Hypertension, 30, 535, 10.1161/01.HYP.30.3.535
Linz, 1999, Interactions among ACE, kinins and NO, Cardiovasc Res, 43, 549, 10.1016/S0008-6363(99)00091-7
Luft, 1997, Meet the ‘other’ angiotensins, J Mol Med, 75, 157
Ardaillou, 1997, Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects, Curr Opin Nephrol Hypertens, 6, 28, 10.1097/00041552-199701000-00006
Tallant, 1999, Antiproliferative actions of angiotensin-(1–7) in vascular smooth muscle, Hypertension, 34, 950, 10.1161/01.HYP.34.4.950
Handa, 1999, Angiotensin-(1–7) can interact with the rat proximal tubule AT4 receptor system, Am J Physiol, 277, F75
Braszko, 1991, The 3–7 fragment of angiotensin II is probably responsible for its psychoactive properties, Brain Res, 554, 49, 10.1016/0006-8993(91)90996-9
Brosnihan, 1996, Angiotensin-(1–7) dilates canine coronary arteries through kinins and nitric oxide, Hypertension, 27, 523, 10.1161/01.HYP.27.3.523
Paula, 1999, Potentiation of the hypotensive effect of bradykinin by angiotensin-(1–7)-related peptides, Peptides, 20, 493, 10.1016/S0196-9781(99)00031-5
Johnson, 1977, Metabolism of vasoactive peptides by human endothelial cells in culture: angiotensin I converting enzyme (kininase II) and angiotensinase, J Clin Invest, 59, 684, 10.1172/JCI108687
Santos, 1988, Converting enzyme activity and angiotensin metabolism in the dog brainstem, Hypertension, 11, 153, 10.1161/01.HYP.11.2_Pt_2.I153
Chappell, 1989, Identification of angiotensin-(1–7) in rat brain. Evidence for differential processing of angiotensin peptides, J Biol Chem, 264, 16518, 10.1016/S0021-9258(19)84737-3
Chappell, 1990, Processing of angiotensin peptides by NG108-15 neuroblastoma×glioma hybrid cell line, Peptides, 22, 375, 10.1016/0196-9781(90)90095-M
Campbell, 1991, Differential regulation of angiotensin peptide levels in plasma and kidney of the rat, Hypertension, 18, 763, 10.1161/01.HYP.18.6.763
Welches, 1991, Prolyl endopeptidase participates in the processing of brain angiotensin, J Hypertension, 9, 631, 10.1097/00004872-199107000-00008
Santos, 1992, Production of angiotensin-(1–7) by human vascular endothelium, Hypertension, 19, II56
Yamamoto, 1992, In vivo metabolism of angiotensin I by neutral endopeptidase (EC3.4.24.11) in spontaneously hypertensive rats, Hypertension, 19, 1201, 10.1161/01.HYP.19.6.692
Kohara, 1993, Angiotensin-(1–7) in the spontaneously hypertensive rat, Peptides, 11, 883, 10.1016/0196-9781(93)90063-M
Ferrario, 1994, A new myocardial conversion of angiotensin I, Curr Opin Cardiol, 9, 520, 10.1097/00001573-199409000-00004
Neves, 1995, Metabolism of angiotensin I in isolated rat hearts. Effect of angiotensin converting enzyme inhibitors, Biochem Pharmacol, 50, 1451, 10.1016/0006-2952(95)02049-7
Campbell, 1995, Angiotensin peptides in spontaneously hypertensive and normotensive donryu rats, Hypertension, 25, 928, 10.1161/01.HYP.25.5.928
Yamada, 1998, Converting enzyme determines the plasma clearance of angiotensin-(1–7), Hypertension, 98, 496, 10.1161/01.HYP.32.3.496
Chappell, 2000, Release of angiotensin-(1–7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition, Hypertension, 35, 348, 10.1161/01.HYP.35.1.348
Lawrence, 1990, An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma, J Hypertens, 8, 715, 10.1097/00004872-199008000-00005
Greene, 1982, Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II, Hypertension, 4, 178, 10.1161/01.HYP.4.2.178
Snyder, 1985, A human platelet angiotensin I-processing system: identification of components and inhibition of angiotensin-converting enzyme by product, J Biol Chem, 260, 7857, 10.1016/S0021-9258(17)39531-5
Marcic, 1999, Enhancement of bradykinin and resensitization of its B2 receptor, Hypertension, 33, 835, 10.1161/01.HYP.33.3.835
Orlowski, 1979, Purification and properties of a prolyl endopeptidase from rabbit brain, J Neurochem, 33, 461, 10.1111/j.1471-4159.1979.tb05176.x
Tan, 1993, Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C): similarity to both serine carboxypeptidase and prolylendopeptidase families, J Biol Chem, 268, 16631, 10.1016/S0021-9258(19)85465-0
Iyer, 1998, Angiotensin-(1–7) contributes to the antihypertensive effects of blockade of the renin–angiotensin system, Hypertension, 31, 356, 10.1161/01.HYP.31.1.356
Chappell, 1998, Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme, Hypertension, 31, 362, 10.1161/01.HYP.31.1.362
Deddish, 1998, N-domain specific substrate and c-domain inhibition of angiotensin-converting enzyme: angiotensin-(1–7) and Keto-ACE, Hypertension, 31, 912, 10.1161/01.HYP.31.4.912
Kohara, 1991, Angiotensin-(1–7): a member of circulating angiotensin peptides, Hypertension, 17, 131, 10.1161/01.HYP.17.2.131
Luque, 1996, Effects of captopril related to increased levels of prostacyclin and angiotensin-(1–7) in essential hypertension, J Hypertens, 14, 799, 10.1097/00004872-199606000-00017
Yamada, 1999, Differential response of angiotensin peptides in the urine of hypertensive animals, Regul Pept, 80, 57, 10.1016/S0167-0115(99)00005-1
Iyer, 1998, Vasodepressor actions of angiotensin-(1–7) unmasked during combined treatment with lisinopril and losartan, Hypertension, 31, 699, 10.1161/01.HYP.31.2.699
Fagundes-Moura, 1997
Schiavone, 1988, Release of vasopressin from the rat hypothalamo–neurohypophysial system by angiotensin-(1–7) heptapeptide, Proc Natl Acad Sci USA, 85, 4095, 10.1073/pnas.85.11.4095
Ferrario, 1990, Renin, converting enzyme and angiotensin peptides: a review, 1
Brosnihan, 1988, Biotransformation of angiotensins in the central nervous system, Ther Res, 9, 48
Simões e Silva, 1997, Renal actions of angiotensin-(1–7), Braz J Med Biol Res, 30, 503, 10.1590/S0100-879X1997000400012
Chappell, 1998, Antihypertensive effects of angiotensin-(1–7), Braz J Med Biol Res, 31, 1205, 10.1590/S0100-879X1998000900014
Ferrario, 1998, Angiotensin-(1–7): a bioactive fragment of the renin–angiotensin system, Regul Pept, 78, 13, 10.1016/S0167-0115(98)00134-7
Chappell, 1998, Differential actions of angiotensin-(1–7) in the kidney, Kidney Int, 4, S3, 10.1038/sj.ki.4490555
Averill, 1999, Angiotensin peptides and the baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata, Brain Res Bull, 51, 119, 10.1016/S0361-9230(99)00237-3
Campagnole-Santos, 1989, Cardiovascular effects of angiotensin (1–7) microinjected into the dorsal medulla of rats, Am J Physiol, 257, H324
Silva, 1993, Cardiovascular effects produced by microinjection of angiotensin-(1–7) on vasopressor and vasodepressor sites of the ventrolateral medulla, Brain Res, 613, 321, 10.1016/0006-8993(93)90920-I
Ambühl, 1992, Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones, Regul Pept, 38, 111, 10.1016/0167-0115(92)90049-Z
Diz, 1997, Hypothalamic substance P release. Attenuated angiotensin responses in mRen2(27) transgenic rats, Hypertension, 29, 510, 10.1161/01.HYP.29.1.510
Gironacci, 1994, Effects of angiotensin II and angiotensin-(1–7) on the release of [3H]norepinephrine from rat atria, Hypertension, 24, 457, 10.1161/01.HYP.24.4.457
Campagnole-Santos, 1992, Differential baroreceptor reflex modulation by centrally infused angiotensin peptides, Am J Physiol, 263, R89
Benter, 1993, Cardiovascular actions of angiotensin-(1–7), Peptides, 14, 679, 10.1016/0196-9781(93)90097-Z
Dellipizzi, 1994, Natriuretic action of angiotensin-(1–7), Br J Pharmacol, 11, 1, 10.1111/j.1476-5381.1994.tb14014.x
Pörsti, 1994, Release of nitric oxide by angiotensin-(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptor, Br J Pharmacol, 111, 652, 10.1111/j.1476-5381.1994.tb14787.x
Moriguchi, 1995, Opposing actions of angiotensin-(1–7) and angiotensin II in the brain of transgenic hypertensive rats, Hypertension, 25, 1260, 10.1161/01.HYP.25.6.1260
Freeman, 1996, Angiotensin-(1–7) inhibits vascular smooth muscle cell growth, Hypertension, 28, 104, 10.1161/01.HYP.28.1.104
Li, 1997, Angiotensin-(1–7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide, Hypertension, 29, 394, 10.1161/01.HYP.29.1.394
Machado, 1999, Opposing actions of angiotensins on angiogenesis, Life Sci, 66, 67, 10.1016/S0024-3205(99)00562-7
Kono, 1986, Biological activities of angiotensin II-(1–6) hexapeptide and angiotensin II-(1–7) heptapeptide in man, Life Sci, 38, 1515, 10.1016/0024-3205(86)90565-5
Fitzsimons, 1971, The effect on drinking of peptide precursor and of short chain peptide fragments of angiotensin II injected into the rat diencephalon, J Physiol, 214, 295, 10.1113/jphysiol.1971.sp009433
Trachte, 1990, Prostaglandin production in response to angiotensin-(1–7) in rabbit isolated vasa deferentia, Prostaglandins, 39, 385, 10.1016/0090-6980(90)90120-K
Santos, 1992, Angiotensin-(1–7) is a potent anti-diuretic peptide in rats, Braz J Med Biol Res, 25, 651
Mahon, 1995, The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1–7) or carbachol, Neuroscience, 69, 199, 10.1016/0306-4522(95)00238-E
Muthalif, 1998, Signal transduction mechanisms involved in angiotensin-(1–7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells, J Pharmacol Exp Ther, 284, 388
Gorelik, 1998, Angiotensin-(1–7) induces bradykinin-mediated relaxation in porcine coronary artery, J Pharmacol Exp Ther, 286, 403
Fontes, 2000, Angiotensin peptides acting at the rostral ventrolateral medulla contribute to the hypertension of TGR(mRen2)27 transgenic rats, Physiol Gen, 2, 137, 10.1152/physiolgenomics.2000.2.3.137
Ye, 1996, Angiotensin II and angiotensin-(1–7) effects on free cytosolic sodium, intracellular pH, and the Na+–H+ antiporter in vascular smooth muscle, Hypertension, 27, 72, 10.1161/01.HYP.27.1.72
Tan, 2000, Actions of angiotensin peptides on the rabbit pulmonary artery, Life Sci, 66, 1839, 10.1016/S0024-3205(00)00507-5
Rowe, 2000, Angiotensin III depressor action in the conscious rabbit is blocked by losartan but not PD123319, Hypertension, 35, 130, 10.1161/01.HYP.35.1.130
Nishimura, 1999, The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells, Thromb Haemost, 82, 1516
Cox, 1999, Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues, Br J Pharmacol, 127, 1256, 10.1038/sj.bjp.0702652
Yang, 1968, New enzymatic route for the inactivation of angiotensin, Nature, 218, 1224, 10.1038/2181224a0
Santos, 1990, The renin–angiotensin system during acute myocardial ischemia in dogs, Hypertension, 15, I121, 10.1161/01.HYP.15.2_Suppl.I121
Benter, 1995, Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1–7), Hypertension, 26, 1138, 10.1161/01.HYP.26.6.1138
Oliveira, 1996, Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats, Hypertension, 27, 1284, 10.1161/01.HYP.27.6.1284
Britto, 1997, Role of angiotensin-(1–7) in the modulation of the baroreflex in renovascular hypertensive rats, Hypertension, 30, 549, 10.1161/01.HYP.30.3.549
Bomtempo, 1998, Interaction of bradykinin and angiotensin-(1–7) in the central modulation of the baroreflex control of heart rate, J Hypertens, 16, 1797, 10.1097/00004872-199816120-00013
Gerken, 1992, Centrally infused bradykinin increases baroreceptor reflex sensitivity, Hypertension, 19, II176
Dampney, 1994, Functional organization of central pathways regulating the cardiovascular system, Physiol Rev, 74, 323, 10.1152/physrev.1994.74.2.323
Sirret, 1977, Distribution of angiotensin II receptors in rat brain, Brain Res, 122, 299, 10.1016/0006-8993(77)90296-7
Song, 1992, Mapping of angiotensin II receptor subtype heterogeneity in rat brain, J Comp Neurol, 316, 467, 10.1002/cne.903160407
Mendelsohn, 1984, Autoradiographic localization of angiotensin II receptors in rat brain, Proc Natl Acad Sci, 81, 1575, 10.1073/pnas.81.5.1575
Casto, 1984, Cardiovascular actions of microinjections of angiotensin II in the brain stem of rats, Am J Physiol, 246, R811
Rettig, 1986, Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solitarii, Brain Res, 364, 233, 10.1016/0006-8993(86)90835-8
Casto, 1986, Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats, Am J Physiol, 250, R193
Campagnole-Santos, 1988, Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii, Hypertension, 11, I167, 10.1161/01.HYP.11.2_Pt_2.I167
Michelini, 1990, Angiotensin II as a modulator of baroreceptor reflexes in the brainstem of conscious rats, Hypertension, 15, I45, 10.1161/01.HYP.15.2_Suppl.I45
Barnes, 1988, Neuronal responses to angiotensin II in the in vitro slice from the canine medulla, Hypertension, 11, 680, 10.1161/01.HYP.11.6.680
Campagnole-Santos, 1990, Actions of angiotensin peptides after partial denervation of the solitary tract nucleus, Hypertension, 15, I34, 10.1161/01.HYP.15.2_Suppl.I34
Barnes, 1990, Angiotensin II and angiotensin-(1–7) excite neurons in the canine medulla in vitro, Brain Res Bull, 24, 275, 10.1016/0361-9230(90)90215-L
Chaves, 1995, Evidence that endogenous angiotensin-(1–7) participates in the modulation of the baroreflex at the nucleus tractus solitarii, Hypertension, 25, 1389
Diz, 1996, Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin-(1–7), 225
Andreatta, 1988, The ventrolateral medulla: a new site of action of the renin–angiotensin system, Hypertension, 11, I163, 10.1161/01.HYP.11.2_Pt_2.I163
Allen, 1988, Angiotensin receptor binding and pressor effect in cat subretrofacial nucleus, Am J Physiol, 255, H1011
Sasaki, 1990, Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla, Hypertension, 15, 274, 10.1161/01.HYP.15.3.274
Li, 1992, Angiotensin II excites vasomotor neurons but not respiratory neurons in the rostral and caudal ventrolateral medulla, Brain Res, 77, 161, 10.1016/0006-8993(92)90551-J
Mosqueda-Garcia, 1990, Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats, J Pharmacol Exp Ther, 255, 374
Muratani, 1991, Effects of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats, Am J Physiol, 260, R977
Saigusa, 1993, Renal sympathetic baroreflex effects of angiotensin II infusions into the rostral ventrolateral medulla of the rabbit, Clin Exp Pharmacol Physiol, 20, 351, 10.1111/j.1440-1681.1993.tb01703.x
Sesoko, 1995, Modulation of baroreflex function by angiotensin II endogenous to the caudal ventrolateral medulla, Brain Res, 671, 38, 10.1016/0006-8993(94)01315-9
Saigusa, 1996, Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla, Am J Physiol, 271, H1015
Ito, 1996, Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone, Am J Physiol, 270, R1317
Fontes, 1994, Evidence that angiotensin-(1–7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptor, Brain Res, 665, 175, 10.1016/0006-8993(94)91171-1
Fontes, 1997, Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats, Brain Res, 750, 305, 10.1016/S0006-8993(96)01476-X
Santos, 1994, Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors, Brain Res Bull, 35, 293, 10.1016/0361-9230(94)90104-X
Averill, 1994, Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and l-glutamate in rostral ventrolateral medulla, Brain Res, 665, 245, 10.1016/0006-8993(94)91344-7
Hirooka, 1997, Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit, Brain Res, 772, 107, 10.1016/S0006-8993(97)00861-5
Head, 1996, Role of AT1 receptors in the central control of sympathetic vasomotor function, Clin. Exp. Pharmacol. Physiol., S93, 10.1111/j.1440-1681.1996.tb02820.x
Lima, 1996, Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade, Immunopharmacology, 33, 305, 10.1016/0162-3109(96)00049-5
Mullins, 1990, Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene, Nature, 344, 541, 10.1038/344541a0
Bader, 1993, Renin gene expression and hypertension in transgenic animals, 60
Lima, 1999, Hemorrhage increases the pressor effect of angiotensin-(1–7) but not of angiotensin II at the rat ventrolateral medulla, J Hypertens, 17, 1145, 10.1097/00004872-199917080-00014
Felix, 1991, Neurophysiological responses to angiotensin-(1–7), Hypertension, 17, 1111, 10.1161/01.HYP.17.6.1111
Ambühl, 1994, [7-d-Ala]-Angiotensin-(1–7): selective antagonism of angiotensin-(1–7) in the rat paraventricular nucleus, Brain Res Bull, 35, 289, 10.1016/0361-9230(94)90103-1
Caruso-Neves, 2000, Angiotensin-(1–7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule, Biochem Biophys Acta
Dellipizzi, 1992, Renal actions of angiotensin-(1–7): comparison with angiotensin II, Pharmacologist, 34, 326
Pawloski-Dahm, 1992, Chronic intravenous infusion of angiotensin-(1–7) produces increases in circulating vasopressin but not arterial pressure, Hypertension, 20, 69
Andreatta-Van Leyen, 1993, Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1–7), Kidney Int, 44, 932, 10.1038/ki.1993.334
Botelho, 1994, Plasma angiotensin-(1–7) levels is increased by water deprivation, salt load and hemorrhage, Peptides, 15, 723, 10.1016/0196-9781(94)90103-1
Garcia, 1994, Angiotensin-(1–7) has a biphasic effect on fluid absorption in the proximal straight tubule, J Am Soc Nephrol, 5, 1133, 10.1681/ASN.V541133
Farina, 1995, Angiotensin-(1–7) has a biphasic effect on frog (Rana catesbeiana) skin osmotic permeability, Hypertension, 25, 1409
Benter, 1995, Antihypertensive actions of angiotensin-(1–7) in spontaneously hypertensive rats, Am J Physiol, 269, H313
Hilchey, 1995, Association between the natriuretic action of angiotensin-(1–7) and selective stimulation of renal prostaglandin I2 release, Hypertension, 25, 1238, 10.1161/01.HYP.25.6.1238
Santos, 1996, Evidence for a physiological role of angiotensin-(1–7) in the control of hydroelectrolyte balance, Hypertension, 27, 875, 10.1161/01.HYP.27.4.875
Handa, 1996, Renal actions of angiotensin-(1–7): in vivo and in vitro studies, Am J Physiol, 270, F141
Machado, 1999
Heller, 2000, Effect of intrarenal infusion of angiotensin-(1–7) in the dog, Kidney Blood Press Res, 23, 89, 10.1159/000025959
Heyne, 1995, Renal response to angiotensin-(1–7) in anesthetized rats, Kidney Int, 47, 975
Vallon, 1997, Effect of intratubular application of angiotensin-(1–7) on nephron function, Kidney Blood Press Res, 20, 233, 10.1159/000174151
Simões e Silva, 1998, Diuresis and natriuresis produced by long term administration of a selective angiotensin-(1–7) antagonist in normotensive and hypertensive rats, Regul Pept, 74, 177, 10.1016/S0167-0115(98)00038-X
Block, 1988, Immunocytochemical localization of angiotensin (1–7) in the rat forebrain, Peptides, 9, 1395, 10.1016/0196-9781(88)90208-2
Calka, 1993, Angiotensin-(1–7) and nitric oxide synthase in the hypothalamo-neurohypophysial system, Brain Res Bull, 30, 677, 10.1016/0361-9230(93)90099-W
Krob, 1998, Angiotensin-(1–7) immunoreactivity in the hypothalamus of (mRen-2d)27 transgenic rat, Brain Res, 798, 36, 10.1016/S0006-8993(98)00384-9
Moriguchi, 1994, Differential regulation of central vasopressin in transgenic rats harbouring the mouse Ren-2 gene, Am J Physiol, 267, R786
Erdös, 1990, Renal metabolism of angiotensin I and II, Kidney Int, 38, 24
Senanayake, 1994, Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats, Peptides, 15, 919, 10.1016/0196-9781(94)90051-5
Ferrario, 1998, Characterization of angiotensin-(1–7) in the urine of normal and essential hypertensive subjects, Am J Hypertens, 11, 137, 10.1016/S0895-7061(97)00400-7
Vallon, 1998, 7-d-Ala-angiotensin-(1–7) blocks renal actions of angiotensin-(1–7) in the anesthetized rat, J Cardiovasc Pharmacol, 32, 164, 10.1097/00005344-199807000-00025
Paula, 1995, Angiotensin-(1–7) potentates the hypotensive effects of bradykinin in conscious rats, Hypertension, 26, 1154, 10.1161/01.HYP.26.6.1154
Lima, 1997, Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1–7) in normotensive and hypertensive rats, Hypertension, 30, 542, 10.1161/01.HYP.30.3.542
Hecker, 1997, ACE inhibitor potentiation of bradykinin-induced venoconstriction, Br J Pharmacol, 121, 1475, 10.1038/sj.bjp.0701281
Fernandes, 2000, Potentiation of bradykinin by angiotensin-(1–7) in mesenteric microvessels of spontaneously hypertensive rats, FASEB J, 14, A674
Almeida, 2000, Angiotensin-(1–7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart, Braz J Mol Biol Med, 10.1590/S0100-879X2000000600012
Jaiswal, 1992, Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors, Hypertension, 19, 49
Jaiswal, 1993, Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells, Hypertension, 21, 900, 10.1161/01.HYP.21.6.900
Seyedi, 1995, Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation, Hypertension, 26, 164, 10.1161/01.HYP.26.1.164
Osei, 1993, Differential responses to angiotensin-(1–7) in the feline mesenteric and hindquarters vascular beds, Eur J Pharmacol, 234, 35, 10.1016/0014-2999(93)90703-K
Abbas, 1997, Angiotensin-(1–7) induces bradykinin-mediated hypotensive responses in anesthetized rats, Hypertension, 30, 217, 10.1161/01.HYP.30.2.217
Oliveira, 1999, Synergistic effect of angiotensin-(1–7) on bradykinin arteriolar dilatation in vivo, Peptides, 20, 1195, 10.1016/S0196-9781(99)00123-0
Sasaki, 2000, Angiotensin-(1–7) induced endothelium-independent vasodilation in normotensive control subjects and essential hypertensive patients, Circulation, 100, 174
Tran, 1997, Angiotensin-(1–7) and the rat aorta: modulation by the endothelium, J Cardiovasc Pharmacol, 30, 676, 10.1097/00005344-199711000-00019
Mendes, 1999, Interaction between angiotensin-(1–7) and kinins in the renal hemodynamic
Widdop, 1999, Cardiovascular effects of angiotensin-(1–7) in conscious spontaneously hypertensive rats, Hypertension, 34, 964, 10.1161/01.HYP.34.4.964
Meng, 1993, Comparative effects of angiotensin-(1–7) and angiotensin II on piglet pial arterioles, Stroke, 24, 2041, 10.1161/01.STR.24.12.2041
Ren, 1999, Receptor-mediated vasodilation effect of angiotensin 1–7 (Ang 1–7) in the isolated afferent arteriole (Af-Art), Am J Hypertens, 12, 58A, 10.1016/S0895-7061(99)80191-5
Nakamoto, 1995, Angiotensin-(1–7) and nitric oxide interaction in renovascular hypertension, Hypertension, 25, 796, 10.1161/01.HYP.25.4.796
Feterik, 1999, Mechanisms of endothelium-dependent relaxation to angiotensin-(1–7) in canine femoral and middle cerebral arteries, Circulation, 100, 2897
Strawn, 1999, Angiotensin-(1–7) reduces smooth muscle growth after vascular injury, Hypertension, 33, 207, 10.1161/01.HYP.33.1.207
Neves, 1997, Effect of angiotensin-(1–7) on reperfusion arrhythmias in isolated rat hearts, Braz J Med Biol Res, 30, 801, 10.1590/S0100-879X1997000600016
van-Rodijnen, 1999, Angiotensin-(1–7) constricts renal microvessels in the isolated perfused hydronephrotic rat kidney preparation, A2339
Kumagai, 1990, Biological activity of angiotensin-(1–7) heptapeptide in the hamster heart, Hypertension, 15, I29, 10.1161/01.HYP.15.2_Suppl.I29
Roks, 1999, Angiotensin-(1–7) is a modulator of the human renin–angiotensin system, Hypertension, 34, 296, 10.1161/01.HYP.34.2.296
Ueda, 2000, Angiotensin-(1–7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man, Hypertension, 35, 998, 10.1161/01.HYP.35.4.998
Mahon, 1994, Angiotensin-(1–7) is an antagonist at the type 1 angiotensin II receptor, J Hypertens, 12, 1377, 10.1097/00004872-199412000-00010
Bovy, 1989, A carboxy-terminus truncated analogue of angiotensin II [Sar1] angiotensin II-(1–7)-amide, provides an entry to a new class of angiotensin II antagonists, J Med Chem, 32, 520, 10.1021/jm00123a002
Hanahan, 1996, Patterns emerging of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7
Sage, 1997, Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis, Trends Cell Biol, 7, 182, 10.1016/S0962-8924(97)01037-4
Fernandez, 1985, Neo-vascularization produced by angiotensin II, J Lab Clin Med, 105, 141
Le Noble, 1991, Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo, Eur J Pharmacol, 195, 305, 10.1016/0014-2999(91)90552-2
Hu, 1996, Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelin-1 and -3 and angiotensin II in a rat sponge model, Br J Pharmacol, 117, 545, 10.1111/j.1476-5381.1996.tb15225.x
Andrade, 1996, Angiotensin-II-induced angiogenesis in sponge implants in mice, Int J Microcirc Clin Exp, 16, 302, 10.1159/000179189
Tallant, 1997, Bovine aortic endothelial cells contain an angiotensin-(1–7) receptor, Hypertension, 29, 388, 10.1161/01.HYP.29.1.388
Neuß, 1994, Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferation, Biochem Biophys Res Commun, 204, 1334, 10.1006/bbrc.1994.2609
Nickening, 1997, Characterization of angiotensin receptors on human skin fibroblasts, J Mol Med, 75, 217, 10.1007/s001090050106
Machado, 2000, P13
Garg, 1989, Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J Clin Invest, 83, 1774, 10.1172/JCI114081
Sakkoula, 1997, Involvement of nitric oxide in inhibition of angiogenesis by interleukin-2, Br J Pharmacol, 122, 793, 10.1038/sj.bjp.0701436
Tsurumi, 1997, Reciprocal relation between VEGF and NO in the regulation of endothelial integrity, Nature Med, 3, 879, 10.1038/nm0897-879
Shirotani, 1991, U-61431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells, Prostaglandins, 41, 97, 10.1016/0090-6980(91)90023-9
Nilsson, 1984, Prostaglandin E inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor, Atherosclerosis, 54, 77, 10.1016/0021-9150(84)90107-2
Feener, 1998, The biochemical and physiological characteristics of receptors, Adv Drug Del Rev, 29, 197, 10.1016/S0169-409X(97)00079-3
Diz, 1992, Differential actions of angiotensin II and angiotensin-(1–7) on transmitter release, Hypertension, 19, II41, 10.1161/01.HYP.19.2_Suppl.II41
Baracho, 1998, Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1–7) in water-loaded rats, Braz J Med Biol Res, 31, 1221, 10.1590/S0100-879X1998000900016
Jaiswal, 1991, Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells, Am J Physiol, 260, R1000
Rowe, 1995, Angiotensin-(1–7) binding at angiotensin II receptors in the rat brain, Regul Pept, 56, 139, 10.1016/0167-0115(95)00010-9
Bouley, 1998, N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor, Eur J Pharmacol, 343, 323, 10.1016/S0014-2999(97)01549-5
Widdowson, 1993, Binding of [3H]angiotensin II and [3H]DuP 753 (losartan) to rat liver homogenates reveals multiple sites. Relationship to AT1a- and AT1b-type angiotensin receptors and novel nonangiotensin binding sites, Peptides, 14, 829, 10.1016/0196-9781(93)90121-V
Chansel, 1994, Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells, Am J Physiol, 266, F384
Li, 1997, Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-I contractions in canine coronary arteries, J Pharmacol Exp Ther, 281, 1065
Gironacci, 1999, Angiotensin-(1–7) binds at the type 1 angiotensin II receptors in rat renal cortex, Regul Pept, 84, 51, 10.1016/S0167-0115(99)00067-1
Jaiswal, 1993, Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved, J Pharmacol Exp Ther, 265, 664
Jaiswal, 1991, Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes, Hypertension, 17, 1115, 10.1161/01.HYP.17.6.1115
Carey, 2000, Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function, Hypertension, 35, 155, 10.1161/01.HYP.35.1.155
Zhou, 1993, A novel angiotensin receptor subtype on rat mesangium: coupling to adenylyl cyclase, Hypertension, 21, 1035, 10.1161/01.HYP.21.6.1035
Dendorfer, 2000, Potentiation of the vascular responses to kinins by inhibition of myocardial kininases, Hypertension, 35, 32, 10.1161/01.HYP.35.1.32
Textor, 1981, Evidence for bradykinin potentiation by angiotensin congeners in conscious rats, Am J Physiol, 240, H255
Salgado, 1983, Acute changes in the renin–angiotensin system modify bradykinin and angiotensin reactivity and metabolism in conscious rats, Hypertension, 5, V172, 10.1161/01.HYP.5.6_Pt_3.V172
Danser, 1999, Quinaprilat and angiotensin-(1–7) potentiate bradykinin-induced vasorelaxation via different mechanisms, Hypertension, 34, 714
Davie, 1999, Effect of angiotensin-(1–7) and bradykinin in patients with heart failure treated with an ACE inhibitor, Hypertension, 34, 457, 10.1161/01.HYP.34.3.457
Stanziola, 1999, Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats, Am J Hypertens, 12, 1021, 10.1016/S0895-7061(99)00090-4